Stockreport

PAVmed Inc (PAVM) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Growth Initiatives [Yahoo! Finance]

PAVmed Inc.  (PAVM) 
US:NASDAQ Investor Relations: ir.pavm.com
PDF EsoGuard Test Volume: 3,664 tests, a 29% increase from Q3 2025. Cash Burn Rate: $1.5 million for Q4 2025. Equity Method Investment in Lucid: $34 million at year-end [Read more]